Company news

Orthofix Medical Inc. news in 2022

Orthofix Medical Inc.'s news releases, calls and decks from 2022, newest first.

View company

Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures

December 21, 2022

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

November 17, 2022

Orthofix Medical Announces Participation in Upcoming Stifel Healthcare Conference

November 9, 2022

Orthofix Reports Third Quarter 2022 Results

November 2, 2022

Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022

October 24, 2022

Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures

October 12, 2022

Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

October 11, 2022

Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results

October 10, 2022

Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company

October 10, 2022

Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting

October 9, 2022

Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference

September 13, 2022

Orthofix Reports Second Quarter 2022 Results

August 4, 2022

Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions

August 1, 2022

Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022

July 26, 2022

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

July 25, 2022

Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market

July 12, 2022

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

May 30, 2022

Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference

May 15, 2022

Orthofix Reports First Quarter 2022 Results

May 5, 2022

FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions

May 3, 2022

Orthofix and MTF Biologics Expand Partnership Agreement

May 2, 2022

Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022

April 27, 2022

Orthofix Announces New Business Unit President

April 7, 2022

Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System

March 15, 2022

Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results

February 24, 2022

Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures

February 21, 2022

Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022

February 9, 2022

Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems

January 18, 2022

Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results

January 9, 2022

Calls in 2022

Decks in 2022